Dose-response study of topical minoxidil in male pattern baldness

米诺地尔 医学 男性型秃发 皮肤病科 安慰剂 头皮 随机对照试验 内科学 替代医学 病理
作者
Elise A. Olsen,Elizabeth R. DeLong,Madeline Weiner
出处
期刊:Journal of The American Academy of Dermatology [Elsevier]
卷期号:15 (1): 30-37 被引量:62
标识
DOI:10.1016/s0190-9622(86)70138-2
摘要

Eighty-nine healthy men with male pattern baldness completed a 6-month double-blind, placebo-controlled study of 0.01 %, 0.1 %, 1 %, and 2% topical minoxidil. Subjects on 2% topical minoxidil had a statistically significant increase in mean total target area hair count over baseline compared to the placebo, 0.01%, and 0.1 % topical minoxidil groups (p = 0.04). Changes from baseline were more impressive with the 2% topical minoxidil group but not significantly different from the 1% topical minoxidil group in all parameters of objective response to treatment. The investigator, however, rated more subjects as having at least a moderate cosmetic response to treatment in the 2% versus 1% topical minoxidil treatment group. These results indicate that 1% topical minoxidil is the lowest effective concentration of topical minoxidil for male pattern baldness of those tested. Because of the more impressive changes in hair counts and the cosmetic preference for the 2% versus 1% topical minoxidil, 2% topical minoxidil may be the standard preferred treatment for male pattern baldness. (J Am Acad Dermatol 15:3037, 1986.) Eighty-nine healthy men with male pattern baldness completed a 6-month double-blind, placebo-controlled study of 0.01 %, 0.1 %, 1 %, and 2% topical minoxidil. Subjects on 2% topical minoxidil had a statistically significant increase in mean total target area hair count over baseline compared to the placebo, 0.01%, and 0.1 % topical minoxidil groups (p = 0.04). Changes from baseline were more impressive with the 2% topical minoxidil group but not significantly different from the 1% topical minoxidil group in all parameters of objective response to treatment. The investigator, however, rated more subjects as having at least a moderate cosmetic response to treatment in the 2% versus 1% topical minoxidil treatment group. These results indicate that 1% topical minoxidil is the lowest effective concentration of topical minoxidil for male pattern baldness of those tested. Because of the more impressive changes in hair counts and the cosmetic preference for the 2% versus 1% topical minoxidil, 2% topical minoxidil may be the standard preferred treatment for male pattern baldness. (J Am Acad Dermatol 15:3037, 1986.)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Owen应助zj采纳,获得10
刚刚
简隋英发布了新的文献求助10
刚刚
hututu完成签到,获得积分10
1秒前
甜的瓜完成签到,获得积分10
2秒前
yydssss完成签到,获得积分10
3秒前
jjlyy完成签到,获得积分10
5秒前
酷波er应助杰a采纳,获得10
5秒前
5秒前
5秒前
Ikejima完成签到,获得积分10
7秒前
翁雁丝完成签到 ,获得积分10
7秒前
葳葳发布了新的文献求助10
7秒前
KD完成签到,获得积分10
8秒前
剑履上殿完成签到,获得积分10
9秒前
123完成签到 ,获得积分10
10秒前
KD发布了新的文献求助10
11秒前
JKH完成签到,获得积分10
12秒前
14秒前
科研通AI2S应助慈祥的翠桃采纳,获得10
14秒前
科研通AI2S应助慈祥的翠桃采纳,获得10
14秒前
情怀应助慈祥的翠桃采纳,获得30
14秒前
科研通AI2S应助慈祥的翠桃采纳,获得10
15秒前
15秒前
15秒前
科研通AI2S应助慈祥的翠桃采纳,获得10
15秒前
15秒前
15秒前
科研通AI2S应助慈祥的翠桃采纳,获得10
15秒前
16秒前
灰灰喵完成签到 ,获得积分10
16秒前
刘小小完成签到 ,获得积分10
17秒前
小巧的香氛完成签到 ,获得积分10
18秒前
可yi1关注了科研通微信公众号
18秒前
19秒前
li发布了新的文献求助10
21秒前
yangxt-iga完成签到,获得积分20
21秒前
粗暴的海豚完成签到,获得积分10
21秒前
HEIKU应助王九八采纳,获得10
23秒前
Chief完成签到,获得积分10
32秒前
FDY完成签到,获得积分10
35秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Semiconductor Process Reliability in Practice 1500
歯科矯正学 第7版(或第5版) 1004
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
中国区域地质志-山东志 560
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3242047
求助须知:如何正确求助?哪些是违规求助? 2886366
关于积分的说明 8243024
捐赠科研通 2555001
什么是DOI,文献DOI怎么找? 1383192
科研通“疑难数据库(出版商)”最低求助积分说明 649658
邀请新用户注册赠送积分活动 625417